angiotensin ii has been researched along with 17-alpha-hydroxyprogesterone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chambaz, EM; Cochet, C; Feige, JJ | 1 |
Mellinger, RC; Wisgerhof, M; Zafar, MS | 1 |
Butkus, A; Coghlan, JP; Denton, DA; Saines, D; Scoggins, BA; Whitworth, JA | 1 |
3 other study(ies) available for angiotensin ii and 17-alpha-hydroxyprogesterone
Article | Year |
---|---|
Type beta transforming growth factor is a potent modulator of differentiated adrenocortical cell functions.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adrenal Cortex; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Angiotensin II; Animals; Cattle; DNA Replication; Hydroxyprogesterones; Peptides; Pregnenolone; Progesterone; Steroid 17-alpha-Hydroxylase; Steroids; Transforming Growth Factors | 1986 |
Failure of angiotensin II to stimulate increases in concentrations of adrenal androgens, 17-hydroxyprogesterone, or adrenocorticotropin in congenital 21-hydroxylase deficiency.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Androgens; Angiotensin II; Dexamethasone; Fludrocortisone; Humans; Hydroxyprogesterones; Male; Posture; Steroid Hydroxylases | 1983 |
Plasma 4-pregnene-17 alpha, 20 alpha-diol-3-one (17 alpha, 20 alpha-dihydroxyprogesterone) and 17 alpha-hydroxyprogesterone in man.
Topics: 17-alpha-Hydroxyprogesterone; Addison Disease; Adolescent; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Circadian Rhythm; Contraceptives, Oral; Dexamethasone; Diet, Sodium-Restricted; Female; Humans; Hydroxyprogesterones; Male; Menopause; Menstruation | 1983 |